Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
Go back to Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 86.73 -0.38 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.11 | 52 Week High | $8.22 | |||
| Open | $86.77 | 52 Week Low | $3.07 | |||
| Day High | $87.01 | P/E | N/A | |||
| Day Low | $85.50 | EPS | $-1.30 | |||
| Volume | 1,104,381 | |||||

